The physico-chemical properties of salmeterol and fluticasone propionate in different solvent environments
- 1 May 2000
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 200 (2) , 279-288
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Impurity profiling in bulk pharmaceutical batches using 19F NMR spectroscopy and distinction between monomeric and dimeric impurities by NMR-based diffusion measurementsJournal of Pharmaceutical and Biomedical Analysis, 1999
- The Effect of lonic Strength on Liposome–Buffer and 1-Octanol–Buffer Distribution CoefficientsJournal of Pharmaceutical Sciences, 1998
- Characterisation of impurities in bulk drug batches of fluticasone propionate using directly coupled HPLC–NMR spectroscopy and HPLC–MSJournal of Pharmaceutical and Biomedical Analysis, 1997
- A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 1997
- Fluticasone propionate — an update on preclinical and clinical experienceRespiratory Medicine, 1995
- SalmeterolMedicinal Research Reviews, 1995
- The determination in human plasma of 1-hydroxy-2-naphthoic acid following administration of salmeterol xinafoateJournal of Pharmaceutical and Biomedical Analysis, 1995
- The anti‐inflammatory profile of fluticasone propionateAllergy, 1995
- Determination of Salmeterol in Rat and Dog Plasma by High-Performance Liquid Chromatography with Fluorescence DetectionJournal of Pharmaceutical Sciences, 1993
- The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta‐ adrenoceptor agonists.British Journal of Clinical Pharmacology, 1991